What Does an EpiPen Cost in 2026?

EpiPen is the brand name for an epinephrine auto-injector manufactured and marketed by Viatris (formerly Mylan). Epinephrine is a synthetic form of adrenaline used for emergency treatment of severe allergic reactions, including anaphylaxis triggered by bee stings, peanuts, shellfish, medications, and other allergens. A single EpiPen 2-Pak contains two auto-injectors, each preloaded with 0.3 mg of epinephrine (0.15 mg in the junior EpiPen Jr formulation for children under 66 lbs). Both brand and generic versions are FDA-approved for self-administration outside a clinical setting, which classifies them as Medicare Part D drugs rather than Part B drugs. The Inflation Reduction Act of 2022 did not include epinephrine in the first or second rounds of Medicare price negotiation, so the IRA Maximum Fair Price provisions do not apply to EpiPen as of 2026.

EpiPen's list price history is one of the most scrutinized in American healthcare. Between 2009 and 2016, the price of an EpiPen 2-pack rose more than 500 percent, drawing congressional hearings and prompting Mylan to launch an authorized generic at roughly half the brand price. The FDA cleared Teva's fully substitutable generic epinephrine auto-injector in August 2018, opening the market to true generic competition. By 2026, the generic two-pack is available with a GoodRx coupon for as low as $169 to $179 at large retail chains, while the brand EpiPen 2-pack still carries a list price of $650 to $750. Patients with commercial insurance and a Viatris savings card can pay as little as $0 out of pocket for the brand; patients without coverage should compare the generic equivalent as the primary cost-reduction strategy. Always confirm that the dispensed product matches the prescription dosage (0.3 mg versus 0.15 mg Jr) since the two are not interchangeable.

Patients navigating EpiPen cost in 2026 should evaluate four distinct pathways: the generic epinephrine auto-injector at a pharmacy using a GoodRx or SingleCare coupon; the Viatris savings card if commercially insured; the Viatris Patient Assistance Program if uninsured and at or below 400 percent of the federal poverty level; and Medicare Part D coverage if Medicare-eligible. Medicaid covers epinephrine auto-injectors in all 50 states, generally with a nominal $1 to $4 copay and prior authorization requirements that vary by state. Families managing severe allergies often need two sets of auto-injectors (one for home, one for school or work), so the cost-per-unit matters in each prescription fill. The federal poverty level income thresholds used by the Viatris PAP are updated annually in January; this page reflects 2026 HHS federal poverty guidelines.

What EpiPen Costs by Point of Pay (2026)

The price you pay depends almost entirely on WHERE you pay. The same epipen can cost many times more at a hospital than at your local pharmacy:

Why Hospitals Charge So Much

EpiPen is primarily a self-carried, community-emergency medication, not a hospital-dispensed drug. Most patients administer their own epinephrine in the field and then proceed to the emergency department for monitoring. When a hospital emergency department administers an epinephrine dose from its own stock, however, the facility charges can be far higher than the retail auto-injector price. Hospital chargemasters routinely list epinephrine administration at several hundred to several thousand dollars per episode, driven by facility fees, nursing time, administration supply costs, and pharmacy markup applied to the drug acquisition cost. Emergency department billing often uses the J0171 HCPCS code for physician-administered epinephrine injection (0.1 mg per unit), not the auto-injector J-code, which can result in unexpected cost breakdowns on the itemized bill.

Three structural factors drive the gap between the pharmacy retail price of a generic epinephrine auto-injector (around $175 to $300) and what a hospital emergency department may bill for the same drug. First, hospitals purchase epinephrine in bulk ampule and prefilled syringe form, at a very low acquisition cost, and apply a significant percentage markup to the drug cost before adding facility fees. Second, each hospital sets its own chargemaster price independent of outside reference benchmarks for emergency medications. Third, emergency department charges are typically bundled into a facility fee that combines drug, nursing, room, and supply costs, making the per-drug charge hard to isolate on the bill. If you receive a hospital bill with a line item for epinephrine above $500, request an itemized statement and compare the drug code (NDC or J0171) against the wholesale acquisition cost. Charges far above $150 per 1 mg ampule are common dispute targets.

Patient Assistance Programs

Viatris, the manufacturer of EpiPen and the authorized generic epinephrine auto-injector, operates two affordability programs for patients who cannot afford their out-of-pocket costs. The first is the Viatris EpiPen Savings Card for commercially insured patients. The second is the Viatris Patient Assistance Program (PAP) for uninsured patients with household income at or below 400 percent of the federal poverty level. Without any program, a cash-paying patient pays $650 to $750 for the brand-name EpiPen 2-pack. With the PAP, qualifying patients can receive EpiPen at no cost.

Medicare Part D

EpiPen is covered under Medicare Part D as a self-administered injectable prescription drug. By CMS requirement, all Medicare Part D plans must include at least one epinephrine auto-injector product on their formulary, so generic coverage is guaranteed across all Part D plans. Brand-name EpiPen coverage varies by plan and tier; check your specific plan's formulary to confirm brand coverage and determine whether prior authorization is required. For 2026, your total annual out-of-pocket spending on all Part D drugs combined is capped at $2,100 under the Inflation Reduction Act of 2022. Once you reach $2,100 in out-of-pocket Part D spending in a calendar year, you pay $0 for covered drugs for the remainder of the year.

Medicare Part B may cover epinephrine when administered in a physician's office, emergency clinic, or ambulance setting (not self-administered), using the HCPCS code J0171 (Injection, adrenalin, epinephrine, 0.1 mg per unit). When EpiPen is physician-administered in an eligible clinical setting, Part B applies with the standard 20 percent coinsurance after the 2026 Part B deductible of $283. However, for the vast majority of EpiPen patients who carry auto-injectors for self-administration in community emergencies, Part D is the relevant coverage. If you receive a bill after a physician-administered epinephrine injection in a doctor's office, confirm whether it was billed under Part B (J0171 code) or as an outpatient pharmacy benefit.

Patients enrolled in Medicare who qualify financially may also apply for Medicare Extra Help (the Low Income Subsidy), which can significantly reduce Part D premiums, deductibles, and copays for all covered drugs including epinephrine auto-injectors. Extra Help eligibility is determined by income and resources independent of the Viatris PAP income threshold. Visit medicare.gov to apply. Additionally, some Medicare Advantage plans include supplemental benefits or lower-tier placements for epinephrine auto-injectors compared to standalone Part D plans; always check your plan's formulary tier for epinephrine before the plan year begins.

Common EpiPen Billing Errors

If you received a bill for EpiPen or epinephrine that is higher than expected, check for these common billing issues before paying in 2026:

• Prior authorization not filed or denied without appeal: many commercial plans and some Medicaid programs require prior authorization for brand-name EpiPen when a generic is available. Confirm with your prescriber's office that the PA was submitted correctly, specifying the formulary tier and medical necessity.
• Savings card not applied at the pharmacy counter for commercially insured patients. The Viatris EpiPen Savings Card must be registered at activatethecard.com and presented at the pharmacy. Ask the pharmacist to reprocess the claim with the savings card BIN/PCN number if it was not applied on your first fill.
• Wrong dosage dispensed: EpiPen 0.3 mg (adult) and EpiPen Jr 0.15 mg (pediatric under 66 lbs) are separate SKUs with different NDC codes. Confirm the dispensed product matches the prescription. Dispensing the wrong strength can result in incorrect claim processing.
• Charged retail cash price when the generic is available and covered: if your plan covers the generic epinephrine auto-injector on a preferred tier, you should not be paying the brand-name EpiPen cash price. Ask your pharmacist to check whether the generic is covered on your plan and whether the prescription allows generic substitution.
• Emergency department billed epinephrine at the facility rate under J0171 when you administered your own EpiPen. If you self-administered your EpiPen before arriving at the hospital, the hospital cannot bill for the drug dose. Only physician-administered epinephrine billable under Part B or facility claims codes applies in that context.

Frequently Asked Questions